Research

2023 Betty Irene Moore Fellowship

 Limit: 1  // PI selected:  J. Rainbow ( College of Nursing) - Competitive Resubmission 

 

The Betty Irene Moore Fellowship for Nurse Leaders and Innovators program is led by the Betty Irene Moore School of Nursing. The nationally ranked UC Davis Graduate School of Management partners with us to provide expertise in leadership, innovation and entrepreneurship. This highly synergistic partnership across schools focuses on preparing the next generation of leaders who are inspired and committed to make a positive impact.

A $37.5 million award from the Gordon and Betty Moore Foundation funds the program. One of the foundation’s early investments was the Betty Irene Moore School of Nursing at UC Davis. With this new school, the foundation sought to advance health and ignite leadership through innovative education, transformative research and bold system change. The fellowship program builds on that vision, and with the UC Davis Graduate School of Management, offers a dynamic opportunity for development in leadership and innovation.

Funding Type
Internal Deadline
External Deadline
12/01/2023
Solicitation Type

NSF 23-604: 2023 National Quantum Virtual Laboratory (NQVL), Quantum Science and Technology Demonstrations (QSTD): I. Pilot Phase

Limit: 1  // PI selected:  M. Eichenfield (Optical Sciences)

 

 

Number of applications allowed per institution: 1

The NSF is introducing the National Quantum Virtual Laboratory (NQVL) concept as an overarching shared infrastructure designed to facilitate the translation from basic science and engineering to the resultant technology, while at the same time emphasizing and advancing its scientific and technical value. The NQVL aims to develop and utilize use-inspired and application-oriented quantum technologies. In the process, NQVL researchers will explore quantum frontiers, foster Quantum Information Science and Engineering (QISE) workforce education and training, engage in outreach activities at all levels, and promote broadening participation, diversity, equity, and inclusion in QISE, thereby lowering barriers at all entry points of the research enterprise.

The engagement of the entire United States (U.S.) QISE community will be necessary for this initiative to succeed, and, indeed, the project is designed to include participation from a full spectrum of organizations who have expertise to contribute. In particular, NSF recognizes that the involvement of industry partners is essential and will welcome these to be a part of the overall structure. Partnerships with other U.S. Federal agencies under the NQI umbrella are also encouraged.

This solicitation lays out a vision for the entire NQVL program that includes Quantum Science and Technology Demonstration (QSTD) projects, support for enabling technologies through Transformative Advances in Quantum Systems (TAQS), as well as a central coordination hub. Proposals for Pilot phase QSTDs are solicited at this time.

This opportunity is for Pilot phase QSTD proposals only.
QSTD Pilot awards may be funded at a level up to $1,000,000 for 12 months per project.

Funding Type
Internal Deadline
External Deadline
10/06/2023
Solicitation Type

2023 Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research

S. Hamilton (Cellular and Molecular Medicine)

UArizona may submit one application.

Program Focus and Overview: The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of the prevention of coronary heart disease or circulatory failure, and improving care for these patients. The Program focuses on basic and translational scientific research. Clinical studies are currently ineligible.

In accordance with Mr. Geneen’s directives the Program supports smaller, mid-sized institutions “rather than major universities or medical complexes which have a demonstrated capacity to raise funds from the public generally.”

Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply.

Eligibility: Each invited institution may submit a single application from a full-time faculty member. United States citizenship is not required. Junior faculty and those with less than $500,000 in direct costs funding at the time of application are encouraged to apply.

Funding Type
Internal Deadline
External Deadline
07/14/2023
Solicitation Type

American Diabetes Association (ADA): 2023 Pathway to Stop Diabetes - Initiator Award (INI) & Accelerator Award (ACE)

M. Dodson ( Pharmacy)

 

UArizona is allowed a maximum of one nomination per grant cycle to one of the Pathway Program Award types: Initiator or Accelerator.

Pathway to Stop Diabetes has a simple, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. We attract and retain brilliant scientists in diabetes. Our three areas of focus—awarding research grants, providing access to scientific and career mentoring from leading diabetes researchers, and creating a diabetes think tank—are each key components of a unique formula to cultivate the next generation of leaders, whose discoveries will stop diabetes and all of its burdens once and for all.

 

Initiator Award (INI)

  • Award Term: Up to 7 years
  • Applicant: Postdoctoral Fellow
  • Maximum Funding: Up to $100,000/year in Phase 1, Up to $325,000/year in Phase 2
  • Support: Project support & PI salary
  • Indirect Support: Up to 10% of directs in Phase 1, Up to 30% of directs in Phase 2
  • Project % Effort Required: 75-100% effort in Phase 1, 50-75% effort in Phase 2
  • Citizenship: Authorized to work in U.S. or U.S. possessions
  • Description: This two-phased award is designed to support the transition of scientists from mentored training to independent research faculty.
  • Eligibility: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
  • Support: Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.

 

 

Accelerator Award (ACE)
 

  • Award Term: Up to 5 years
  • Applicant: Early Career Faculty
  • Maximum Funding: $325,000/year
  • Support: Project support & PI salary
  • Indirect Support: Up to 30% of directs
  • Project % Effort Required: 25-50% effort
  • Citizenship: Authorized to work in U.S. or U.S. possessions
  • Description: This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs.
  • Eligibility: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
  • Support: Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.

 

Funding Type
Internal Deadline
External Deadline
08/01/2023
Solicitation Type

Johnson & Johnson: 2023 Women in STEM2D Scholars Program

The sponsor has confirmed that the  Women in STEM2D Scholars Program is under review; therefore, the solicitation won't be open during 2023. 

 

 

  • K. Renner (Orthopaedic Surgery) - Engineering discipline
  • K. Rodriguez (Veterinary Medicine) - Science discipline
  • A. Ryan (Civil and Architectural Engineering and Mechanics) -  Technology discipline

Math, Manufacturing & Design disciplines are still available. 

 

 

 

UArizona may submit a limit of 6 proposals, one per award category: Science, Technology, Engineering, Math, Manufacturing & Design. 

When the 2023 solicitation and guidelines are posted by the sponsor, the internal competition will be updated. 

The Johnson & Johnson Scholars Award Program aims to fuel development of female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their careers, in each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design. The awards will fund one woman per STEM2D discipline who has completed her advanced degree, who is working as an assistant professor (or global equivalent faculty position) and who is not yet tenured at an accredited university, institution or design school. The goal is to fuel the research passion of the awarded women and inspire career paths in their respective STEM2D fields. Johnson & Johnson is looking to identify global women leading in both their research fields and leading as mentors, to be a vision for girls and other women in STEM2D.

 

The Scholars Award is a three-year award in the gross amount of $150,000, which will be paid to the University (the “Recipient”) for the benefit of the Johnson & Johnson Scholar and her research, with the understanding that the Recipient will administer the funds. The Scholars Award will be paid in three (3) installments of U.S. $50,000 per year of the three-year scholarship period, payable in 2023, subject to compliance with the terms and conditions of the program’s Agreement. Winners achievements will also be showcased at a symposium.

Judges will use the following criteria to evaluate the applications:

  • Scientific/technical expertise exhibited
  • Novelty/innovation of the research
  • Potential impact of the research
  • Feasibility of the research

You must be a woman working in the field(s) of Science, Technology, Engineering, Mathematics, Manufacturing and Design (STEM2D).

You must be an early to mid-career women working within a STEM2D university department at the time of application at an accredited academic university, institution or design school. Examples include a non-tenured assistant professor, assistant professor or associate professor.

The female scholar should have a minimum degree for the appropriate field:

  • Science; M.D., Ph.D.
  • Technology; Ph.D.
  • Engineering; Ph.D.
  • Math; M.S., Ph.D.
  • Manufacturing; Ph.D.
  • Design; M.A., M.S., MDes, MArch, MFA, MLA, Ph.D.
Funding Type
Internal Deadline
External Deadline
09/30/2023
Solicitation Type

DOE DE-FOA-0002740: 2023 BIL Grid Resilience and Innovation Partnerships (GRIP)

No applicants // Limit: 1 // Tickets Available: 1 

 

UArizona may only submit one Concept Paper and one Full Application for each topic area of this funding program.

The BIL is a once-in-a-generation investment in infrastructure, designed to modernize and upgrade American infrastructure to enhance U.S. competitiveness, driving the creation of good-paying union jobs, tackling theclimate crisis, and ensuring stronger access to economic, environmental, and other benefits for disadvantaged communities (DACs). The BIL appropriates more than $62 billion to the Department of Energy (DOE) including funding to support investments to build a clean and equitable energy economy that achieves zero carbon electricity by 2035, and puts the United States on a path to achieve net-zero emissions economy-wide by no later than 2050“ to benefit all Americans. As new load and generation come online as the market moves in line with these goals, deploying the projects that will support a more resilient and reliable grid will be critical. At present, aging grid infrastructure leaves the grid increasingly vulnerable to attacks. The increasing frequency of extreme weather events is leading to energy supply disruptions that threaten the economy, put public health and safety at risk, and can devastate affected communities all over the country.

This FOA seeks applications to address these three goals:
1. Transform community, regional, interregional, and national resilience, including in consideration of future shifts in generation and load
2. Catalyze and leverage private sector and non-federal public capital for impactful technology and infrastructure deployment
3. Advance community benefits 

Funding Type
Internal Deadline
External Deadline
05/19/2023
Solicitation Type

USDA USDA-NIFA-OTHER-009752: 2023 Open Data Framework

No applicants // Limit: 1 // Tickets Available: 1 

This project will build the framework needed to create a neutral and secure data repository and cooperative where producers, universities and not-for-profit entities can store and share data to foster agriculturalinnovation and to support technological progress, production efficiencies, and environmental stewardship. The project must have clear and complete plans to ensure diverse participation, including all land-grant university types, growers, and representatives of all relevant data producer and consumer organizations, with attention to the costs and benefits for all sectors, and with special attention to barriers and value for farmers. 

 

 

2023 V Scholar Cancer Research Grant

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC Research Development (UACC-PreAward@arizona.edu)
The University of Arizona Cancer Center (UACC) can nominate one applicant for the V Scholar Cancer Research Grant.
 

Purpose of Award:

The UACC is seeking nominations for the V Scholar Cancer Research Grant which supports young tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research.

This RFA is specifically for adult cancer research that is focused on laboratory research. This year, we have special interest and funding for therapeutic resistance and welcome research projects in this area. Please note that research areas not included in this scope are epidemiology, behavioral science, and health services research. We also strongly encourage applications from underrepresented minorities in cancer research including Blacks or African Americans, Hispanics or Latinos (non-European), American Indians or Alaska Natives, Native Hawaiians, and other Pacific Islanders who may be eligible for funding through the Stuart Scott Memorial Cancer Research Fund.

The total amount of the grant is $600,000, paid in three annual installments of $200,000. Only direct costs of the research are supported by this award.

Applicant Eligibility

Inclusion: Nominee must be all of the following criteria by the nomination due date.

  • Nominated by their Cancer Center Director or similar high ranking research official.
  • Employed at a non-profit research institution (e.g., 501c3, Section 170).
  • Either a US Citizen or a permanent legal resident in the US. This requirement does not apply to invited Canadian institutions.
  • Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
  • Clinical scientists are eligible if the research institution demonstrates that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
  • V Scholar applicants must have been appointed to their first full-time tenure track Assistant Professor position no more than 5 years prior to the nomination due date, and not yet promoted to Associate Professor (for e.g., must be eligible to apply for PI status on an R01 at your institution.

Exclusion: By the Nomination Due Date, nominee must:

  • NOT be a previous or current V Foundation V Scholar awardee.
  • NOT have accepted or received notification of an R01 award by the nomination due date.
  • NOT have accepted or received award notification of any peer-reviewed, non-mentored single grant that totals or exceeds $750K in total direct funding at ANY point in their professional career. This calculation should exclude indirect costs.
  • NOT have accepted or received award notification of any peer-reviewed, non-mentored funding that exceeds $1M in aggregated total direct funding at ANY point in their professional career. This calculation should exclude indirect costs.

Note: The V Scholar award is intended to support research to leverage these larger awards; so, the nominee should not have already received such awards.

Funding Type
Internal Deadline
Sponsor
External Deadline
04/27/2023
Solicitation Type

2023 Phi Beta Psi Charity Trust Grant

For any other questions, please contact UACC-PreAward@arizona.edu.

 

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC-PreAward@arizona.edu.
The University of Arizona Cancer Center (UACC) can nominate two applicants for the Phi Beta Psi Charity Trust Grant 2023 funding opportunity.

Purpose of Award:

The UACC is seeking nominations for Phi Beta Psi’s Charity Trust Grant 2023. The Phi Beta Psi Sorority is a national, civic, non-profit organization whose National Project is to advance cancer research nationwide to improve prevention, diagnosis, and treatment by providing research grants to qualified investigators addressing original questions and hypotheses to be explored in basic and clinical studies in the field of cancer.

Research applications must be focused on brain, breast, colorectal, endometrial, lung, ovarian, pancreatic, or prostate cancer. Preference is given to Young Investigators with documented evidence of potential for conducting novel research of either basic or clinical aspects of cancer and cancer-related problems. Applications from Established Investigators exploring new and innovative areas of cancer research also will be considered.

Applicant Eligibility:

  • Preference is given to Young Investigators with documented evidence of potential for conducting novel research of either basic or clinical aspects of cancer and cancer-related problems.
  • Applications from Established Investigators exploring new and innovative areas of cancer research also will be considered.
  • Post-doctoral fellows are not eligible.
  • Research assistant professors may be eligible.
  • The gold standard is as follows: if the individual is eligible to submit an R01 from their institution as Principal Investigator then they are eligible to submit a Phi Beta Psi application.

 

Funding Type
Internal Deadline
External Deadline
06/15/2023
Solicitation Type

2024 Pew-Stewart Scholars Program for Cancer Research

T. Sawyer (Biomedical Engineering)

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC Research Development (UACC-PreAward@arizona.edu)

The University of Arizona Cancer Center (UACC) can nominate one applicant for the 2024 Pew-Stewart Scholars Program for Cancer Research which supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer.

Purpose of Award:

In line with The Alexander and Margaret Stewart Trust’s mission to invest in innovative, cutting-edge cancer research that may accelerate and advance progress toward a cure for cancer, applications are invited from nominees conducting cancer research. This program is distinct from the Pew Scholars Program, and it follows a different, but parallel set of guidelines and procedures for nominating an applicant whose research is related to cancer.

This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied cancer research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply. Ideas with the potential to produce an unusually high impact are encouraged.

Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Award Terms

An award of $75,000 per year for four years ($300,000 total) will be provided to the sponsoring institution for use by the Pew-Stewart scholar, subject to annual review of his or her progress. Grant agreements will be issued in August of the award year. Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew-Stewart program.

It is expected that Pew-Stewart scholars will spend at least 80 percent of their time in work or activities related to the accomplishment of their overall research goals (which are not restricted to the specific aims proposed for this award). However, Pew provides flexible support to the general research aims of the Pew-Stewart scholar and does not require effort reporting.

The awarded funds may be used at the discretion of the Pew-Stewart scholar, for personnel, equipment, supplies, or travel directly related to the Pew-Stewart scholar's research and as to best advance his or her research and career. Specifically:

  • The amount of the award that may be used for the principal investigator’s salary is limited to $12,500 per year (including benefits) or $50,000 over the duration of the grant. There are no limits on student or postdoctoral salaries.
  • Not more than 8 percent ($24,000) of the total award value may be allocated for facilities and administration (F&A) charges or indirect costs (IDCs).
  • Should the funds not be immediately required, they may be accumulated and carried over through the grant period and, with written approval of the program office, the grant may receive a no-cost extension for one additional year (without additional funds).
  • Subawards are allowed.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew-Stewart program. If you have questions concerning eligibility, please contact Kara Coleman, project director, Pew Biomedical Programs at 215-575-4925 or Pew-Stewart@pewtrusts.org in advance of applying.

Applicant Eligibility:

Candidates must meet all of the following eligibility requirements:

  • Due to COVID-19-related research disruptions, we are adding an additional year of eligibility so that individuals in the first four years of their assistant professor position are eligible to apply.
  • Candidates must have been awarded a doctorate in biomedical sciences, medicine or a related field.
  • As of Aug. 31, 2023, nominees must be running an independent lab and hold full-time appointments at the rank of assistant professor or equivalent.
  • Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible.
  • Candidates must not have been appointed as an assistant professor at any institution prior to June 12, 2019. Time spent in clinical internships, residencies, in work toward board certification, or on parental or medical leave does not count as part of this four-year limit. Candidates who need an eligibility extension due to leave or other reasons should contact Pew’s program office.
  • Candidates may apply two times in total
  • Candidates should be conducting creative, interdisciplinary, basic or translational cancer research. This program is not designed to fund clinical trial research.
  • If an applicant's university has more than one eligible nominating institution or campus, that applicant may apply from only one institution; the applicant may not reapply in a subsequent year from a different one.
  • Candidates may not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now